FutureFuel to Release First Quarter 2024 Financial Results on May 9, 2024
CLAYTON, Mo., April 08, 2024 (GLOBE NEWSWIRE) — FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals […]
TSX News -
Exco Technologies Limited Announces Second Quarter Results on May 1, 2024
TORONTO, April 08, 2024 (GLOBE NEWSWIRE) — Exco Technologies Limited (TSX – XTC) today announced that it will report its […]
TSX News -
Dundee Precious Metals Delivers Strong First Quarter Gold Production; Announces Timing of First Quarter Financial Results
TORONTO, April 08, 2024 (GLOBE NEWSWIRE) — Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) announced preliminary production […]
Brunswick Signs Right to Repurchases 0.5% NSR on Select Claims at Mirage
MONTREAL, April 08, 2024 (GLOBE NEWSWIRE) — Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; “BRW” or the “Company”) is pleased […]
Sirios grants Brunswick right to purchase a royalty on select claims of the Mirage Property
MONTREAL, April 08, 2024 (GLOBE NEWSWIRE) — The directors of Sirios Resources Inc. (TSX-V: SOI; OTCQB: SIREF) (“Sirios”) are pleased […]
NRSInsights’ March 2024 Retail Same-Store Sales Report
March same-store sales jumped 7.2% year-over-year, the highest rate of increase since June 2023 Inflationary pressures remained subdued – average […]
Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing
WARRINGTON, Pa., April 08, 2024 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), today announced that […]
Verita announces claims leadership team
NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) — Verita (Verita CSG, Inc.), a Managing General Underwriting (MGU) company, is excited […]
Angi Appoints Jeff Kip as CEO
DENVER, April 08, 2024 (GLOBE NEWSWIRE) — Angi (NASDAQ: ANGI), the leading and most comprehensive solution for all home care […]
Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference
SAN FRANCISCO, April 08, 2024 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company […]
